Date published: 2026-5-18

1-800-457-3801

SCBT Portrait Logo
Seach Input

CALCA Inhibitors

CALCA inhibitors belong to a distinct chemical class primarily characterized by their ability to interact with and regulate the activity of the calcitonin gene-related peptide (CGRP). The CALCA gene encodes for CGRP, a neuropeptide that plays a crucial role in various physiological processes within the human body. By targeting the specific mechanisms involved in CGRP synthesis, release, or receptor binding, CALCA inhibitors can modulate CGRP signaling pathways. This class of inhibitors is typically designed to exert their effects at the molecular level, often targeting enzymes or receptors involved in the CGRP cascade.

Through these interactions, CALCA inhibitors aim to regulate the intricate balance of CGRP in different tissues and systems, contributing to the overall homeostasis of the body. Due to the essential role of CGRP in various biological processes, CALCA inhibitors have attracted significant attention from the scientific community for their potential in further understanding the intricate interplay of neuropeptides and for their potential applications in research and development.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Olcegepant

204697-65-4sc-478307
10 mg
$490.00
(0)

Olcegepant (CAS 204697-65-4) is a potent and selective inhibitor of the CALCA protein, also known as calcitonin gene-related peptide (CGRP). By specifically targeting the CGRP receptor, Olcegepant disrupts the binding and signaling pathways associated with this protein. This inhibition has been widely studied in biochemical and cellular research to understand CGRP-related mechanisms and the role of CALCA in various biological processes.